Lundbeck presents phase 1b data on Parkinson’s drug candidate
#Lundbeck #Parkinson's disease #phase 1b #clinical trial #drug candidate #neurology #pharmaceuticals
📌 Key Takeaways
- Lundbeck has released phase 1b clinical trial data for a Parkinson's disease drug candidate.
- The data suggests the candidate is safe and well-tolerated in early-stage testing.
- Results indicate potential efficacy in addressing Parkinson's symptoms, though further trials are needed.
- This development marks progress in Lundbeck's neurology-focused pipeline.
🏷️ Themes
Pharmaceuticals, Neurology
Entity Intersection Graph
No entity connections available yet for this article.